IMV Inc.

OTC: IMVIF · Healthcare · Biotechnology

Canadian filerHQ Dartmouth, NSCIK 0001734768Reports USD

#1 of 1,394 Healthcare companies by revenue

EA Score

——

FH —DQ —GM —SS 43

v0.1 · 5/100 weight · pillars only

↑ listing tenure, workforce scale · ↓ Piotroski F, filing timeliness

Methodology →

Revenue TTM

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

-$38.0M

Employees

Market cap

$23.4k

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Net income-$38.0M-$38.0M2022

Total assets$31.3M$31.3M2022

Liabilities$38.0M$38.0M2022

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

IMV Inc. earned -$38.0M in FY2022 net income.

Peers · Healthcare

Ocean Biomedical, Inc.——Quantum Medical Transport, Inc.——MabCure Inc.——Nanobac Pharmaceuticals, Incorporated——

Key facts

CEOAndrew Hall

SectorHealthcare

IndustryBiotechnology

HeadquartersDartmouth, NS

ExchangeOTC: IMVIF

Employees63

IPO date2013-04-08

Latest filings

6-K2023-07-26 6-K2023-05-08 6-K2023-03-31 6-K2023-03-28 6-K2023-03-16 20-F2023-03-16 6-K2023-03-09 6-K2023-02-13

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.